The innovative drug sector of Hong Kong stocks continued to weaken in the afternoon. Zhaoyan Pharmaceutical fell more than 7%, Rongchang Biotech, Kanglong Chemical, and Goli Pharmaceutical-B fell more than 5%, followed by Gloria Ying and Nuochengjianhua.

The innovative drug sector of Hong Kong stocks continued to weaken in the afternoon. Zhaoyan Pharmaceutical fell more than 7%, Rongchang Biotech, Kanglong Chemical, and Goli Pharmaceutical-B fell more than 5%, followed by Gloria Ying and Nuochengjianhua.